XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
$1.54−0.08 (-4.94%)
Close on Nov 18, 2026Market cap $14.57MP/E –Yield –
XTL Biopharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2024 it was -$1.67M. The highest annual figure on record is -$851.00K in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$1.67M | – |
| FY2020 | Dec 31, 2020 | -$851.00K | – |
| FY2019 | Dec 31, 2019 | -$910.00K | – |
| FY2016 | Dec 31, 2016 | -$1.73M | – |
| FY2015 | Dec 31, 2015 | -$1.86M | – |
See a number that looks wrong?